Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
INO-5401 by Inovio Pharmaceuticals for Glioblastoma Multiforme (GBM): Likelihood of Approval
INO-5401 is under clinical development by Inovio Pharmaceuticals and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...